Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,322 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07191860Recruiting
Coated balloon for non-cancerous airway narrowing
This trial tests a special balloon coated with a medicine (paclitaxel) to open narrowed windpipes. It is for people whose windpipe is blocked by scar tissue from a ventilator, transplant, or other non-cancer causes, not from cancer.
Baltimore, MarylandAges 22 years+ - NCT07185997RecruitingPhase 3
Study of Firmonertinib for first-line treatment of advanced lung cancer with uncommon EGFR mutations
This trial tests a new pill called firmonertinib against standard EGFR inhibitor pills for people with advanced non-small cell lung cancer that has certain uncommon EGFR mutations. It aims to see if firmonertinib works better in stopping the cancer from growing.
Fullerton, CaliforniaAges 18 years+ - NCT06945705RecruitingPhase 2
Targeted therapy for EGFR-mutant lung cancer with brain spread
This trial tests a combination of two targeted pills (furmonertinib and anlotinib) as a first treatment for people with advanced EGFR-mutant non-small cell lung cancer that has spread to the brain. It aims to see if this combination works better than the standard approach for controlling the cancer.
ZhengzhouAges 18 years+ - NCT06945978Recruiting
Testing a blood test to predict treatment response in advanced pancreatic cancer
This study looks at a special blood test (miRNA panel) to see if it can help predict how well treatment works for people with advanced pancreatic cancer. If you are starting FOLFIRINOX for the first time, you may be able to join.
São Paulo, São PauloAges 18 years+ - NCT07187869RecruitingPhase 1
Cabozantinib plus nivolumab for kidney cancer with bone spread
This study tests whether adding a drug called cabozantinib to standard nivolumab treatment helps fight kidney cancer that has spread to bone. It aims to understand how the bone environment changes during treatment.
Houston, TexasAges 18 years+ - NCT07189195RecruitingPhase 1
TR-002 for advanced solid tumors and pancreatic cancer
This trial tests a new drug called TR-002 in people with advanced solid tumors (cancer that has spread) who have run out of standard treatment options. It includes a specific group for people with pancreatic cancer that is no longer responding to chemotherapy.
Sacramento, CaliforniaAges 18 years+ - NCT07191808Enrolling by invitation
Laser therapy for Bell's palsy recovery
This trial tests if low-level laser therapy can help people with Bell's palsy recover faster. It is for adults with a recent diagnosis, mild to moderate facial weakness, and no prior treatment for this episode.
FaisalābadAges Any age - NCT07191522Recruiting
Light therapy for gum disease around dental implants
This trial tests if a special light treatment (photodynamic therapy) can help treat infection and inflammation around dental implants without surgery. It may be an option for people with mild to moderate peri-implantitis who don't smoke and have healthy gums otherwise.
Almada, Monte Da CaparicaAges 18 years+ - NCT07187882Recruiting
Skin cell transplant for vitiligo treatment
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
Beijing, Beijing MunicipalityAges 8–65 - NCT07185126Recruiting
New PTSD therapy for children ages 6-14
This study tests a new therapy for children with PTSD. It aims to help children aged 6-14 reduce trauma symptoms by teaching them skills to manage distressing memories and feelings.
KyivAges 6–14 - NCT07189390RecruitingPhase 2
Probiotic study for infants who had antibiotics at birth
This study tests whether giving a probiotic (a 'good' bacteria) to babies who received antibiotics shortly after birth can help their developing gut and immune system. Participants will receive a daily probiotic or placebo for about 6 weeks, and their health will be monitored.
Adelaide, South AustraliaAges Up to 4 weeks - NCT07189377RecruitingPhase 4
Light, ex-vivo treatment and antivirals for lungs from hepatitis B donors
This trial tests a new way to safely use donor lungs that carry the hepatitis B virus (HBV). It combines a special light treatment, ex-vivo lung perfusion (cleaning the lungs outside the body), and antiviral medicines to prevent infection in the recipient. If you are on the lung transplant list and have been vaccinated against hepatitis B, this study may help expand your donor options.
Toronto, OntarioAges 18 years+ - NCT07185724RecruitingPhase 4
Ketorolac for fresh embryo transfer in IVF
This trial tests whether a medicine called ketorolac (a type of NSAID, similar to ibuprofen) can improve outcomes when you have a fresh embryo transfer during IVF. It may help reduce cramping or inflammation that could affect implantation.
Iowa City, IowaAges 18–37 - NCT07188532Recruiting
Personalized high-dose radiation for Ewing sarcoma
This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.
Phoenix, ArizonaAges 2 years+ - NCT07192146Recruiting
Patient experiences after dental emergency treatment
This study looks at how patients feel after receiving emergency dental treatment for tooth pain. It aims to understand what factors affect their recovery and satisfaction.
BangkokAges 18 years+ - NCT07187817Recruiting
Sequential biologic treatments for psoriasis
This trial looks at how different biologic treatments work when used one after another for people with plaque psoriasis. It may help find the best order of treatments to keep your skin clear.
Bath, SomersetAges 18 years+ - NCT07188506Recruiting
Youth suicide risk: reducing risk factors in young people
This study looks at suicide risk factors in young people with mood disorders (like depression or bipolar disorder) and tests ways to reduce those risks. It may help if you are between 18 and 25, have a mood disorder, and can undergo an MRI.
Roma, RMAges 18–25 - NCT07185035RecruitingEarly Phase 1
Testing natural killer cells for leftover lung nodules
This trial is testing a new treatment using your own immune cells (called NK cells) to fight leftover high-risk lung nodules that cannot be surgically removed. It is for people who have already had some cancerous nodules removed and are looking for another option.
NanjingAges 18–70 - NCT07191717RecruitingPhase 2
Imlunestrant and abemaciclib for early ER+ breast cancer
This trial tests whether adding two targeted drugs, imlunestrant and abemaciclib, to your usual hormone therapy can lower the chance of your breast cancer coming back. It is for people with early-stage ER+ breast cancer who have no signs of cancer on scans but have tiny amounts of tumor DNA in their blood (called ctDNA).
Los Angeles, CaliforniaAges 18 years+ - NCT07193134RecruitingPhase 1/Phase 2
Gene-modified skin graft for RDEB
This trial tests a new skin graft made with your own cells that have been genetically modified to produce a missing protein (collagen 7). It's for people with RDEB, a severe blistering condition, and aims to see if the graft can heal wounds safely.
Toronto, OntarioAges 7 years+ - NCT07185022Recruiting
Clot-busting drug through artery for medium-vessel stroke
This trial tests a clot-busting drug given directly into the arteries of the brain for people who have had a stroke due to a blockage in a medium-sized artery. It aims to see if this treatment can help improve recovery when started up to 72 hours after symptoms begin.
Fuyang, AnhuiAges 18 years+ - NCT07185061Recruiting
Sound treatment for chronic tinnitus
This study tests whether a special sound-based treatment can help people with chronic tinnitus (ringing in the ears). If your tinnitus has lasted more than six months and you don't have other ear or brain problems, you may be able to join.
Nanjing, JiangsuAges 18 years+ - NCT07188441RecruitingPhase 2
Treating newly diagnosed central malignant germ cell tumors with teniposide and cisplatin
This trial tests a combination of two chemotherapy drugs—teniposide and cisplatin—for people who have just been diagnosed with a malignant germ cell tumor in the brain. The goal is to see if this treatment is safe and effective.
Guangzhou, GuangdongAges 5 years+ - NCT07192991Recruiting
Neuroendocrine Cancers: Patient Journey and Treatment in Latin America
This study looks at how people with certain neuroendocrine cancers (including small cell lung cancer and large-cell neuroendocrine carcinoma) are diagnosed and treated in Latin America. It aims to understand the patient journey and improve future care.
Buenos Aires, Buenos AiresAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,322 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.